Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease via Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota

Overview of attention for article published in Frontiers in Pharmacology, July 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 15 X users

Citations

dimensions_citation: 32 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 15 X posts from 15 X users, with an upper bound of 183,448 followers.

Berberrubine, a Main Metabolite of Berberine, Alleviates Non-Alcoholic Fatty Liver Disease <em>via</em> Modulating Glucose and Lipid Metabolism and Restoring Gut Microbiota https://t.co/2mUpH0cUFs

25 Jul 2022

Reply Repost Favourite

RT @Brunorm84: Berberrubine, a Main Metabolite of Berberine, Alleviates #NAFLD Disease via Modulating Glucose and Lipid #Metabolism and Res…

11 Jul 2022

Reply Repost Favourite

RT @Brunorm84: Berberrubine, a Main Metabolite of Berberine, Alleviates #NAFLD Disease via Modulating Glucose and Lipid #Metabolism and Res…

10 Jul 2022

Reply Repost Favourite

RT @Brunorm84: Berberrubine, a Main Metabolite of Berberine, Alleviates #NAFLD Disease via Modulating Glucose and Lipid #Metabolism and Res…

10 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.